A new study concludes the U.S. pharmaceutical industry might be wasting more than $50 billion every year in manufacturing expenses.
The finding is part of the largest empirical study ever performed of pharmaceutical manufacturing and the U.S. Food and Drug Administration's monitoring policies.
The study was conducted by Jackson Nickerson, professor of organization and strategy at Washington University in St. Louis, and Jeffrey Macher, assistant professor of strategy and economics at Georgetown University.
"We undertook the project to understand how the FDA regulates and pharmaceutical manufacturers produce, so we could see where there may be conflicts that inhibit advances in manufacturing," Nickerson said. "Our policy goal is to understand both sides of the coin so that we could contribute to improving the regulatory environment, thereby altering the pharmaceutical industry's incentives to maintain and in some cases enhance product quality but for a much lower cost."
The researchers collected data from 42 manufacturing facilities and determined companies extensively using information technology displayed superior manufacturing performance compared with other firms.
They also found the lower in the ranks a company allows employees to make decisions, the higher the company's overall manufacturing performance.
Copyright 2006 by United Press International
Related stories:
Designing semantic software by numbers
A system for creating semantic software could transform application development from a cottage industry to an industrial-style production line. Semantic applications are the next frontier for information science, but creating them is very difficult.
Virtual 3D nanorobots could lead to real cancer-fighting technology
From eliminating the side effects of chemotherapy to treating Alzheimer’s disease, the potential medical applications of nanorobots are vast and ambitious. In the past decade, researchers have made many improvements on the different systems required for developing practical nanorobots, such as sensors, energy supply, and data transmission.
From ink to optics, study of particle mixtures yields fundamental insights
Since the invention of ink over 3,000 years ago, people have exploited the unique properties of colloids, in which particles of one substance are suspended in another. Now, Princeton University chemical engineers have answered a fundamental question about these mixtures in work that may have wide-ranging practical applications, including the manufacturing of medicines and optical fibers.
Sanctions won't stop China violating IP
Imposing trade sanctions is no solution to getting China to comply with intellectual-property rules. Rather, by encouraging Chinese companies to tie up with U.S. rivals on the one hand and getting them to produce goods that require patent protection themselves will be the best way to get the Chinese authorities to abide by international regulations.
Sharp Announces Second Generation 3D Notebook
Following a wake of awards and recognition for the Sharp Actius Notebook line, Sharp Systems of America today announced the availability of the Sharp Actius AL3D. Featuring Sharp’s 3D LCD Screen Technology, the Actius AL3D represents Sharp’s second generation of 3D Technology enhanced notebook systems.
Atlanta firm to develop Ohio University algae bioreactor
(PhysOrg.com) -- Atlanta firm Green Bios Technologies has licensed a new type of algae bioreactor from Ohio University developed by internationally renowned engineering professor David Bayless. The company plans to develop the reactor for customers interested in its diverse potential applications, which include curbing air pollution, treating municipal waste, carbon sequestration and growing feedstock for biofuel or pharmaceutical uses.
A new material could act as a nanofridge for microchips
In the past few years, the design and manufacturing of circuits at nanoscopic scale for integrated devices has become one of the frontier fields in new material science and technology. The significant reduction achieved in these devices often is accompanied by new discoveries in how they behave precisely when the systems are of extremely small dimensions. Understanding this new physics at nanoscopic scale at the same time has enabled researchers to study the possibility of designing new materials with innovative characteristics.
New tool for 'right first time' drug manufacture
A technology which provides high quality images of the crystallisation process marks the next step towards a 'right first time' approach to drug manufacture, according to engineers at the University of Leeds.